Related Experiment Videos
A general method for retrieving the components of a genetically engineered fusion protein
DNA (Mary Ann Liebert, Inc.)
|February 1, 1986
Summary
Researchers developed a novel method using Escherichia coli to create bovine growth hormone (bGH) fusion proteins. These proteins can be specifically cleaved at an acid-labile aspartyl-proline dipeptide site, releasing active bGH.
Area of Science:
- Biotechnology
- Molecular Biology
- Protein Chemistry
Background:
- Recombinant protein production often requires efficient purification strategies.
- Fusion proteins are commonly used to facilitate protein expression and purification.
- Developing methods for site-specific protein cleavage is crucial for obtaining functional proteins.
Purpose of the Study:
- To construct Escherichia coli expression vectors for synthesizing bovine growth hormone (bGH) fusion proteins.
- To investigate the acid-labile cleavage of an aspartyl-proline (Asp-Pro) dipeptide linker.
- To assess the biological activity of released bGH.
Main Methods:
- Construction of expression vectors in E. coli encoding bGH fusion proteins with an Asp-Pro dipeptide linker.
- Utilizing the Bam HI recognition site (GGATCC) to introduce the Asp-Pro codons (GAT-CCX).
- Cleavage of fusion proteins at low pH with guanidine hydrochloride to release bGH.
Main Results:
- Successfully synthesized two distinct bGH fusion proteins using the constructed vectors.
- Demonstrated specific release of the bGH moiety under low pH conditions, dependent on the Asp-Pro dipeptide.
- Confirmed that the released bGH retains anti-bGH immunoreactivity and growth hormone receptor binding ability in vitro.
Conclusions:
- The developed system enables the production of bGH fusion proteins with a cleavable linker in E. coli.
- Acid-labile cleavage at the Asp-Pro dipeptide site provides a specific method for releasing biologically active bGH.
- This approach offers a valuable tool for recombinant protein production and purification.